Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 8–8 | Cite as

Immune checkpoint inhibitor toxicites from FAERS and OoSRs

Clinical study
  • 26 Downloads

Reference

  1. Raschi E, et al. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System. Targeted Oncology : 29 Mar 2019. Available from: URL: http://doi.org/10.1007/s11523-019-00632-w

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations